annb0t
Top 20
Analysts on Wall Street project that ResMed (RMD) will announce quarterly earnings of $2.03 per share in its forthcoming report, representing an increase of 23.8% year over year. Revenues are projected to reach $1.19 billion, increasing 7.9% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.5% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial ...
>>> Read more: Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key Metrics
The consensus EPS estimate for the quarter has undergone an upward revision of 0.5% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial ...
>>> Read more: Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key Metrics
